A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Axitinib Impurity 31 | CAS 1952288-48-0 - Request Quote

Picture of Axitinib Impurity 31

Axitinib Impurity 31

SZ CAT No:SZ-A073065
CAS No
1952288-48-0
Mol.F.
C14H10IN3
Mol.Wt.
347.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Axitinib Impurity 31 is chemically (E)-6-Iodo-3-(2-(pyridin-2-yl)vinyl)-1H-indazole. Axitinib Impurity 31 is supplied with detailed characterization data compliant with regulatory guideline. Axitinib Impurity 31 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Axitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1952288-48-0

Purchase 1952288-48-0

Order 1952288-48-0

Enquire 1952288-48-0

price of 1952288-48-0

1952288-48-0 Supplier

1952288-48-0 Manufacturer

1952288-48-0 Exporter

buy high quality Axitinib Impurity 31

Purchase Axitinib Impurity 31

Axitinib Impurity 31 suppliers

Axitinib Impurity 31 manufacturers

Axitinib Impurity 31 price

Order Axitinib Impurity 31

Enquire Axitinib Impurity 31

Axitinib Impurity 31 cost

Axitinib Impurity 31 Supplier

Axitinib Impurity 31 Distributor

Axitinib Impurity 31 for Method Validation

Axitinib Reference Standard

Axitinib Impurity 31 for ANDA Filing

Axitinib Impurity 31 for Forced Degradation Studies

Axitinib Impurity 31 Identification Standards

Axitinib Impurity 31 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,